- Home
- GLMD vs MTNB Comparison
GLMD vs MTNB Comparison
Compare GLMD & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- MTNB
- Stock Information
- Founded
- GLMD 2000
- MTNB 2013
- Country
- GLMD Israel
- MTNB United States
- Employees
- GLMD N/A
- MTNB N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- GLMD Health Care
- MTNB Health Care
- Exchange
- GLMD Nasdaq
- MTNB Nasdaq
- Market Cap
- GLMD 7.9M
- MTNB 7.9M
- IPO Year
- GLMD 2014
- MTNB N/A
- Fundamental
- Price
- GLMD $1.49
- MTNB $2.13
- Analyst Decision
- GLMD Hold
- MTNB Hold
- Analyst Count
- GLMD 1
- MTNB 1
- Target Price
- GLMD N/A
- MTNB N/A
- AVG Volume (30 Days)
- GLMD 164.0K
- MTNB 1.4M
- Earning Date
- GLMD 09-02-2025
- MTNB 08-14-2025
- Dividend Yield
- GLMD N/A
- MTNB N/A
- EPS Growth
- GLMD N/A
- MTNB N/A
- EPS
- GLMD N/A
- MTNB N/A
- Revenue
- GLMD N/A
- MTNB N/A
- Revenue This Year
- GLMD N/A
- MTNB N/A
- Revenue Next Year
- GLMD N/A
- MTNB N/A
- P/E Ratio
- GLMD N/A
- MTNB N/A
- Revenue Growth
- GLMD N/A
- MTNB N/A
- 52 Week Low
- GLMD $1.15
- MTNB $0.47
- 52 Week High
- GLMD $23.80
- MTNB $5.41
- Technical
- Relative Strength Index (RSI)
- GLMD 44.36
- MTNB 69.03
- Support Level
- GLMD $1.35
- MTNB $1.66
- Resistance Level
- GLMD $1.59
- MTNB $1.90
- Average True Range (ATR)
- GLMD 0.11
- MTNB 0.37
- MACD
- GLMD 0.00
- MTNB 0.07
- Stochastic Oscillator
- GLMD 44.56
- MTNB 57.12
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.